A detailed history of Morgan Stanley transactions in Ardelyx, Inc. stock. As of the latest transaction made, Morgan Stanley holds 3,134,486 shares of ARDX stock, worth $15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,134,486
Previous 3,045,856 2.91%
Holding current value
$15 Million
Previous $22.6 Million 4.31%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.28 - $7.57 $467,966 - $670,929
88,630 Added 2.91%
3,134,486 $21.6 Million
Q2 2024

Oct 17, 2024

BUY
$5.89 - $9.31 $3.75 Million - $5.93 Million
637,146 Added 26.45%
3,045,856 $22.6 Million
Q2 2024

Aug 14, 2024

BUY
$5.89 - $9.31 $3.75 Million - $5.93 Million
637,146 Added 26.45%
3,045,856 $22.6 Million
Q1 2024

Oct 17, 2024

SELL
$6.05 - $9.74 $3.85 Million - $6.21 Million
-637,146 Reduced 20.92%
2,408,710 $17.6 Million
Q1 2024

Aug 16, 2024

SELL
$6.05 - $9.74 $4.82 Million - $7.76 Million
-796,398 Reduced 24.85%
2,408,710 $17.6 Million
Q1 2024

May 15, 2024

SELL
$6.05 - $9.74 $4.82 Million - $7.76 Million
-796,398 Reduced 24.85%
2,408,710 $17.6 Million
Q4 2023

Aug 16, 2024

BUY
$3.29 - $6.64 $523,939 - $1.06 Million
159,252 Added 5.23%
3,205,108 $19.9 Million
Q4 2023

Feb 13, 2024

BUY
$3.29 - $6.64 $224,460 - $453,014
68,225 Added 2.17%
3,205,108 $19.9 Million
Q3 2023

Nov 15, 2023

BUY
$3.3 - $4.83 $5.61 Million - $8.21 Million
1,699,182 Added 118.19%
3,136,883 $12.8 Million
Q2 2023

Aug 14, 2023

SELL
$3.23 - $4.95 $336,817 - $516,176
-104,278 Reduced 6.76%
1,437,701 $4.87 Million
Q1 2023

May 15, 2023

BUY
$2.68 - $4.79 $363,743 - $650,122
135,725 Added 9.65%
1,541,979 $7.39 Million
Q4 2022

Feb 14, 2023

BUY
$1.22 - $2.85 $872,053 - $2.04 Million
714,798 Added 103.38%
1,406,254 $4.01 Million
Q3 2022

Nov 14, 2022

BUY
$0.59 - $1.44 $173,480 - $423,408
294,034 Added 73.99%
691,456 $823,000
Q2 2022

Oct 27, 2022

BUY
$0.51 - $1.17 $57,297 - $131,448
112,349 Added 39.41%
397,422 $235,000
Q2 2022

Aug 15, 2022

BUY
$0.51 - $1.17 $57,297 - $131,448
112,349 Added 39.41%
397,422 $235,000
Q1 2022

Oct 27, 2022

SELL
$0.65 - $1.18 $73,026 - $132,571
-112,349 Reduced 28.27%
285,073 $304,000
Q1 2022

May 13, 2022

SELL
$0.65 - $1.18 $1 Million - $1.82 Million
-1,544,775 Reduced 84.42%
285,073 $304,000
Q4 2021

Feb 14, 2022

SELL
$0.86 - $1.7 $387,150 - $765,297
-450,175 Reduced 19.74%
1,829,848 $2.01 Million
Q3 2021

Nov 15, 2021

BUY
$1.27 - $8.17 $2.9 Million - $18.6 Million
2,280,023 New
2,280,023 $3.01 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $742M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.